Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 90, Issue 1
January 2016
Issue Cover
All Issues
ISSN 0030-2414
EISSN 1423-0232
In this Issue

Journal Name Change

Vol. 1-20 (1948-1966) were published under the journal's former title Oncologia.

Oncology 2016, Vol. 90, No. 1

Clinical Study

Use of Palliative Endocrine Therapy in Patients with Hormone Receptor-Positive Distant Metastatic Breast Cancer: How Often, How Effective, How Long?
Subject Area: Oncology
Uwe Güth; Dorothy Jane Huang; Andreas Schötzau; Seraina Margaretha Schmid
Oncology (2016) 90 (1): 1–9. https://doi.org/10.1159/000439570
View articletitled, Use of Palliative Endocrine Therapy in Patients with Hormone Receptor-Positive Distant Metastatic Breast Cancer: How Often, How Effective, How Long?
Open the PDF for in another window
Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies
Subject Area: Oncology
Rastislav Bahleda; Jackie Baker; Christophe Massard; Sirish M. Gadgeel; Jane E. Rogers; Hassan Izzedine; Eric Deutsch; Jeana L. Garris; Akbar Khan; Emmanuelle Boelle; Sylvie Assadourian; Jean-Charles Soria; Jaffer A. Ajani
Oncology (2016) 90 (1): 10–20. https://doi.org/10.1159/000440958
View articletitled, Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies
Open the PDF for in another window
Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061
Subject Area: Oncology
Linda Cerbone; Cora N. Sternberg; Lisa Sengeløv; Mads Agerbaek; Carla Van Herpen; Sandrine Marreaud; Sandra Collette; Jianping Zhang; Gedske Daugaard
Oncology (2016) 90 (1): 21–28. https://doi.org/10.1159/000440959
View articletitled, Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061
Open the PDF for in another window
Long-Term Toxicity and Quality of Life in Patients Treated for Locally Advanced Cervical Cancer
Subject Area: Oncology
Piera Gargiulo; Laura Arenare; Carmela Pisano; Sabrina Chiara Cecere; Sara Falivene; Stefano Greggi; Rosa Tambaro; Gaetano Facchini; Giampaolo De Palma; Cono Scaffa; Chiara Della Pepa; Sandro Pignata; Marilena Di Napoli
Oncology (2016) 90 (1): 29–35. https://doi.org/10.1159/000441226
View articletitled, Long-Term Toxicity and Quality of Life in Patients Treated for Locally Advanced Cervical Cancer
Open the PDF for in another window
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy
Topic Article Package: Topic Article Package: Diabetes
Subject Area: Oncology
Alessandro Ottaiano; Anna Nappi; Salvatore Tafuto; Guglielmo Nasti; Chiara De Divitiis; Carmela Romano; Antonino Cassata; Rossana Casaretti; Lucrezia Silvestro; Antonio Avallone; Maurizio Capuozzo; Monica Capozzi; Piera Maiolino; Vincenzo Quagliariello; Stefania Scala; Vincenzo Rosario Iaffaioli
Oncology (2016) 90 (1): 36–42. https://doi.org/10.1159/000442527
View articletitled, Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy
Open the PDF for in another window
A Comparison of the Hot Spot and the Average Cancer Cell Counting Methods and the Optimal Cutoff Point of the Ki-67 Index for Luminal Type Breast Cancer
Subject Area: Oncology
Nobuyuki Arima; Reiki Nishimura; Tomofumi Osako; Yasuyuki Nishiyama; Mamiko Fujisue; Yasuhiro Okumura; Masahiro Nakano; Rumiko Tashima; Yasuo Toyozumi
Oncology (2016) 90 (1): 43–50. https://doi.org/10.1159/000441525
View articletitled, A Comparison of the Hot Spot and the Average Cancer Cell Counting Methods and the Optimal Cutoff Point of the Ki-67 Index for Luminal Type Breast Cancer
Open the PDF for in another window

Short Communication

Degree of Rectal Distension Seen on Prostate Radiotherapy Planning CT Scan Is Not a Negative Prognostic Factor in the Modern Era of Image-Guided Radiotherapy
Subject Area: Oncology
Rafael Silverman; Kerstie Johnson; Christina Perry; Santhanam Sundar
Oncology (2016) 90 (1): 51–56. https://doi.org/10.1159/000441225
View articletitled, Degree of Rectal Distension Seen on Prostate Radiotherapy Planning CT Scan Is Not a Negative Prognostic Factor in the Modern Era of Image-Guided Radiotherapy
Open the PDF for in another window
Erratum - Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
Potential of Using qFibrosis Analysis to Predict Recurrent and Survival Outcome of Patients with Hepatocellular Carcinoma after Hepatic Resection
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
  • Online ISSN 1423-0232
  • Print ISSN 0030-2414
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal